List view / Grid view
18 December 2015 | By Victoria White
OMT has leading antibody drug discovery technology and is believed to be the only company in the world offering three transgenic animal platforms for license...
17 December 2015 | By ProteinSimple
Simple Western™ system that can generate up to 96 data points in a single experiment, handling your low, medium or high throughput Simple Western needs…
16 December 2015 | By ProteinSimple
FluorChem M sets a new standard for quantitative Western blot detection...
15 December 2015 | By ProteinSimple
iCE has the resolution of traditional gel IEF but incorporates the advantages of quantitation and automation...
15 December 2015 | By Victoria White
There are thought to be as many as 600,000 protein-protein interactions that could be targets for new drugs. The project seeks to analyse and categorise the important features of these interactions...
15 December 2015 | By Victoria White
The "Takeda-CiRA Joint Programme for iPS Cell Applications" (T-CiRA) will begin research in six core directions to explore clinical applications of stem cells in therapeutic areas including cancer, heart failure and diabetes mellitus...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
14 December 2015 | By ProteinSimple
The FluorChem E Digital Darkroom redefines high-performance Western blot and gel imaging...
13 December 2015 | By ProteinSimple
AlphaImager Mini is a compact and economical digital imaging system, ideal for routine imaging of fluorescent and colorimetric DNA and protein gels...
10 December 2015 | By Victoria White
SRI Biosciences and physician-researchers from Stanford Cancer Institute (SCI) are to pursue development of novel compounds to treat multiple forms of cancer and other conditions...
10 December 2015 | By Victoria White
The partnership will focus on using nanotechnologies based on Cour’s Tolerizing Immune Modifying nanoParticle (TIMP) platform...
7 December 2015 | By Victoria White
The collaboration, facilitated by Johnson & Johnson Innovation, aims to develop new cyclophilin inhibitors for neurodegenerative diseases...
6 December 2015 | By ProteinSimple
This video provides an overview of the features from the Simple Western product range by ProteinSimple, including Wes, Sally Sue, Peggy Sue or NanoPro 1000...
The drug discovery landscape is changing: no longer limited to big pharma, it is now within reach of academics and small consortia alike. Regardless of the setting, drug discovery requirements are always the same: strong biological theory, good chemical starting material and high quality protein samples from which to determine…
5 December 2015 | By ProteinSimple
Ella runs hands-free, multiplex-free, ELISA-free Simple Plex assays. She’ll give you results for multiple samples in 60 minutes flat...
